Jacobs Levy Equity Management’s Medicines Co MDCO Stock Holding History

Jacobs Levy Equity Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-13,440	Closed	-$385K	–	896
2015 Q2	$385K	Sell	13,440 -64,300	-83%	-$1.79M	0.01%	611
2015 Q1	$2.18M	Buy	77,740 +52,460	+208%	+$1.47M	0.04%	358
2014 Q4	$699K	Buy	+25,280	New	+$626K	0.01%	561
2014 Q1	–	Sell	-7,200	Closed	-$278K	–	1054
2013 Q4	$278K	Sell	7,200 -137,129	-95%	-$4.9M	﹤0.01%	823
2013 Q3	$4.84M	Sell	144,329 -166,851	-54%	-$5.31M	0.08%	282
2013 Q2	$9.57M	Buy	+311,180	New	+$10.4M	0.17%	175

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management's MDCO Position: Q3 2015 in Review

Jacobs Levy Equity Management sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 13,440 shares — an estimated $385K sold.

Jacobs Levy Equity Management first reported a position in MDCO in Q2 2013 and held it in 6 quarters. The position peaked at $9.57M in Q2 2013. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

Jacobs Levy Equity Management reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
Jacobs Levy Equity Management sold 13,440 Medicines Co shares in Q3 2015, an estimated $385K.
Jacobs Levy Equity Management first reported a position in Medicines Co in Q2 2013 and held it in 6 quarters.
Jacobs Levy Equity Management's Medicines Co position peaked at $9.57M in Q2 2013.
183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2015, filed 16 Nov 2015.